Discriminative stimulus properties of the novel serotonin (5-HT)(2C) receptor agonist, RO60-0175: A pharmacological analysis

Neuropharmacology

Volumn 38, Issue 3, 1999, Pages 415-423

  Dekeyne, A ^a   Girardon, S ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

5 HT(2A) receptor; 5 HT(2C) receptor; Depression; Drug discrimination; Ro 60 0175; Schizophrenia

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 METHYL 5 ISOTHIAZOLYL)UREA; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CLOZAPINE; MIANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMINOPYRIDINES; ANIMALS; CONDITIONING, OPERANT; ETHYLAMINES; FLUOROBENZENES; INDOLES; MALE; MIANSERIN; PIPERAZINES; PIPERIDINES; PYRAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; REINFORCEMENT (PSYCHOLOGY); SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; THIOPHENES;

EID: 0032978523     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00203-2     Document Type: Article

References (60)

1. 2B receptor function? Br. J. Pharmacol. 117, 178P.
2. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci. 16, 105-110.
3. Boess, F.G., Martin, I.L., 1994. Molecular biology of 5-HT receptors. Neuropharmacology 33, 275-317.
4. 2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl-)-1-methylethylamines and 2-(indenol[1,2-b]pyrrol-1-metylethylamines. Improved therapeutics for obsessive compulsive disorders. J. Med. Chem. 40, 2762-2769.
5. Bourson, A., Wanner, D., Wyler, R., Petit, N., Zwingelstein, C., Rudler, A., Sleight, A.J., 1996. Pharmacologic evaluation of the discriminative stimulus of metachlorophenyl-piperazine. Pharmacol. Biochem. Behav. 53, 107-114.
6. Brunello, N., Masotto, C., Steardo, L., Markstein, R., Racagni, G., 1995. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacol. 13, 177-213.
7. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur. J. Pharmacol. 257, 27-38.
8. Conn, P.J., Sanders-Bush, E., 1987. Central serotonin receptors: effector systems, physiological and regulation. Psychopharmacology 92, 267-277.
9. Coplan, J.D., Gorman, J.M., Klein, D.F., 1992. Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology 6, 189-200.
10. Deakin, J.F.W. 1994. Three distinct roles of 5-HT in anxiety, panic and depression. In: Montgomery S.A., Corn, T.H., (Eds.). Psychopharmacology of depression. British Association for Psychopharmacolgy Monograph 13, 87-101.
11. Duxon, M.S., Flanigan, T.P., Reavley, A.C., Baxter, G.S., Blackburn, T.P., Fone, K.C.F., 1997. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76, 323-329.
12. 2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacology 36, 601-608.
13. 2C receptor messenger RNA in the basal ganglia of adult rats. J. Comp. Neurol. 384, 233-247.
14. 2C receptors in the stimulus effects of hallucinogenic drugs III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology 121, 364-372.
15. 2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology 122, 237-243.
16. 2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology 119, 222-230.
17. 2C receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis. Psychopharmacology 121, 247-356.
18. 2C receptor levels in the rat. Br. J. Pharmacol. 123, 1707-1715.
19. 2B receptor antagonist. J. Med. Chem. 38, 855-857.
20. Frazer, A., 1997. Antidepressants. J. Clin. Psychiatr. 58, 9-25.
21. 2C receptors in mice. Eur. J. Pharmacol. 341, 135-138.
22. Gobert, A., Rivet, J.-M., Audinot, V., Newman-Tancredi, A., Cistarelli, L., Millan, M.J., 1998. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84, 413-429.
23. 2C receptor mode of action. Psychopharmacology 137, 292-302.
24. 2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology 36, 793-802.
25. Glennon, R.A., 1988. Site-selective serotonin agonists as discriminative stimuli. Psychopharmacology 4, 16-31.
26. Herndon, J.L., Pierson, M.E., Glennon, R.A., 1992. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine. Pharmacol. Biochem. Behav. 43, 739-748.
27. 3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J. Pharmacol. Exp. Ther. 264, 1440-1449.
28. 2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol. Behav. Brain Res. 88, 43-49.
29. 2 receptors. J. Pharmacol. Exp. Ther. 263, 276-284.
30. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther. 277, 968-981.
31. 2B receptor agonist, BW 723C86, on three rat models of anxiety. Br. J. Pharmacol. 117, 1443-1448.
32. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117, 427-434.
33. 2C receptor antagonist. Neuropharmacology 36, 609-620.
34. 2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis. Am. Soc. Neurosci. Abstr. 23, 975.
35. Lucki, U., Ward, H.R., Frazer, A., 1989. Effect of 1-(m-Chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl) piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249, 155-164.
36. 2C receptor agonists and antagonists in animal models of anxiety. Eur. Neuropsychopharmacol. Abstr. 5, 4-17.
37. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 286, 913-924.
38. 2A receptors. Eur. J. Pharmacol. 280, R9-R11.
39. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37, 953-955.
40. 2C receptor antagonist, SB 206,553. Neuropharmacology 36, 743-745.
41. 2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur. J. Pharmacol. 325, 9-12.
42. 1C/2 antagonists as therapeutic agents. Drug News Perspect. 5, 397-406.
43. Millan, M.J., 1995. Serotonin (5-HT) and pain: a reappraisal of its role in the light of receptor multiplicity. Semin. Neurosci. 7, 409-419.
44. 2C receptor agonists exhibit antidepressantlike properties in the anhedonia model of depression in rats. Eur. Neuropsychopharmacol. 6, 169-175.
45. Murphy, D.L., Lesch, K.P., Aulakh, C.S., Pigott, T.A., 1991. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol. Rev. 43, 527-552.
46. Pessia, M., Jiang, Z.G., North, R.A., Johnson, S.W., 1994. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654, 324-330.
47. 2C receptors. Mol. Br. Res. 23, 163-178.
48. Prisco, S., Esposito, E., 1995. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br. J. Pharmacol. 116, 1923-1931.
49. Roth, B.L., Meltzer, H.Y., 1995. The role of serotonin in schizophrenia. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 1215-1228.
50. Schreiber, R., Brocco, M., Millan, M.J., 1994. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur. J. Pharmacol. 264, 99-102.
51. 1A agonists. J. Pharmacol. Exp. Ther. 273, 101-112.
52. 1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin. J. Pharmacol. Exp. Ther. 275, 822-831.
53. 2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody effect of 5,7-dihydroxytryptamine. Synapse 26, 45-56.
54. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther. 266, 684-691.
55. 1-adrenoceptor antagonism. J. Clin. Psychopharmacol. 15, 11S-18.
56. 2C serotonin receptors. Nature 374, 542-546.
57. 2B receptor. NeuroReport 7, 1457-1460.
58. Wadenberg, M.-L., 1996. Serotoninergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 20, 325-339.
59. Winter, J.C., Rabin, R.A., 1993. Discriminative stimulus properties of m-chlorophenylpiperazine. Pharmacol. Biochem. Behav. 45, 221-223.
60. 3 receptors. J. Pharm. Pharmacol. 45, 711-714.